AZFamily goes inside Alcor, showing cryonics as real, contested infrastructure rather than just a sci-fi myth
Arizona TV station AZFamily went inside Alcor and showed cryonics as local infrastructure with an address, a price tag, and an on-call team
On April 29, local TV station AZFamily aired a major report from inside Alcor’s building in Scottsdale. On screen: the storage facility, the rapid-response team, the chemistry of vitrification, the pricing, and a debate with bioethicist Arthur Caplan. The report does not offer new evidence that future revival will be possible, but it translates cryonics into grounded, everyday terms: an expensive service with a defined process and its own pricing.
Local television walks into an unremarkable building in an industrial area, shows the Dewar vessels, speaks with Alcor member Rick Lemler, who has already signed the paperwork, and breaks the procedure down step by step. First comes legal death. Then a rapid deployment by DART, the team that begins cooling as soon as it is legally allowed to do so. Our breakdown of The Guardian’s short film about cryonics already showed that the first minutes after cardiac arrest matter more for preservation quality than the nitrogen tank itself; AZFamily presents the same logic in a television format. Then comes about a week of internal work: blood is replaced with tissue-preservation solutions, the temperature is lowered gradually, and only then is the person moved into long-term storage in liquid nitrogen.
Alcor CEO James Arrowood explains cryonics through vitrification - a way of cooling tissue so that ice crystals do not form inside it and tear apart cellular structure. He specifically names M22 as the solution used as a cryoprotectant.
The report also gives hard numbers. Whole-body preservation costs about $220 000. Neuro-preservation, in which only the head is preserved, costs about $80 000-90 000. Viewers see the price of this chance, the service logistics, and immediately run into the question of who can actually afford it.
The segment does not turn into an advertisement, because Caplan is in it.
"If someone is selling you a promise - we’ll freeze the body, and future doctors will wake it up someday - that does not sound plausible to me," says bioethicist Arthur Caplan.
Caplan lists the unresolved problems: the freezing itself, the precise chemical balance, and in the case of neuro-preservation, the added question of how a brain could function at all after such a scenario. But even he acknowledges a more down-to-earth outcome from this line of work: if tissue-preservation methods improve, that could be useful for long-term organ storage and transplantation.
In February, Alcor had already tried to position cryonics within the funeral-services system as a third option alongside burial and cremation. Now a local TV station is explaining that same choice to an ordinary city. Cryonics has become tangible enough to be shown as part of the urban landscape: here is the building, here is the team, here are the prices, here is the critic, here is the person who has already made the bet. That is how the topic enters mass conversation: society first gets used to the existence of contested infrastructure, and only later decides whether to treat it as madness, insurance, or an early version of future medicine.